The Potential Health Care Costs And Resource Use Associated With COVID-19 In The United States: A simulation estimate of the direct medical costs and health care …

SM Bartsch, MC Ferguson, JA McKinnell, KJ O'shea… - Health …, 2020 - healthaffairs.org
With the coronavirus disease 2019 (COVID-19) pandemic, one of the major concerns is the
direct medical cost and resource use burden imposed on the US health care system. We …

Vaccine efficacy needed for a COVID-19 coronavirus vaccine to prevent or stop an epidemic as the sole intervention

SM Bartsch, KJ O'shea, MC Ferguson… - American journal of …, 2020 - Elsevier
Introduction Given the continuing COVID-19 pandemic and much of the US implementing
social distancing owing to the lack of alternatives, there has been a push to develop a vaccine …

[HTML][HTML] Maintaining face mask use before and after achieving different COVID-19 vaccination coverage levels: a modelling study

SM Bartsch, KJ O'Shea, KL Chin, U Strych… - The Lancet Public …, 2022 - thelancet.com
Background Face mask wearing has been an important part of the response to the COVID-19
pandemic. As vaccination coverage progresses in countries, relaxation of such practices is …

Lives and costs saved by expanding and expediting coronavirus disease 2019 vaccination

SM Bartsch, PT Wedlock, KJ O'Shea… - The Journal of …, 2021 - academic.oup.com
Background With multiple coronavirus disease 2019 (COVID-19) vaccines available,
understanding the epidemiologic, clinical, and economic value of increasing coverage levels and …

The clinical and economic burden of norovirus gastroenteritis in the United States

SM Bartsch, KJ O'Shea, BY Lee - The Journal of infectious …, 2020 - academic.oup.com
Background Although norovirus outbreaks periodically make headlines, it is unclear how
much attention norovirus may receive otherwise. A better understanding of the burden could …

The benefits of vaccinating with the first available COVID-19 coronavirus vaccine

SM Bartsch, KJ O'Shea, PT Wedlock, U Strych… - American journal of …, 2021 - Elsevier
Introduction During a pandemic, there are many situations in which the first available
vaccines may not have as high effectiveness as vaccines that are still under development or …

[HTML][HTML] The value of decreasing the duration of the infectious period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection

…, MC Ferguson, PT Wedlock, KJ O'Shea… - PLoS computational …, 2021 - journals.plos.org
Finding medications or vaccines that may decrease the infectious period of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) could potentially reduce transmission in the …

Viral FLIP impairs survival of activated T cells and generation of CD8+ T cell memory

…, GA DosReis, MF Lopes, J O'Shea… - The Journal of …, 2004 - journals.aai.org
Viral FLIPs (vFLIPs) interfere with apoptosis signaling by death-domain-containing
receptors in the TNFR superfamily (death receptors). In this study, we show that T cell-specific …

Can following formula-feeding recommendations still result in infants who are overweight or have obesity?

MC Ferguson, KJ O'Shea, LD Hammer… - Pediatric …, 2020 - nature.com
Background Studies show that by 3 months, over half of US infants receive formula, and
guidelines play a key role in formula feeding. The question then is, what might happen if …

[HTML][HTML] The potential epidemiologic, clinical, and economic value of a universal coronavirus vaccine: a modelling study

SM Bartsch, KJ O'Shea, DC John, U Strych… - …, 2024 - thelancet.com
Background With efforts underway to develop a universal coronavirus vaccine, otherwise
known as a pan-coronavirus vaccine, this is the time to offer potential funders, researchers, and …